Manufacturing

Articles

FDA has granted accelerated approval to Biogen for Aduhelm (aducanumab), a new mAb treatment for Alzheimer’ disease.

FDA Grants Accelerated Approval for Biogen’s Alzheimer’s Drug

Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.

Process intensification in continuous biopharmaceutical processing can change the way the equipment is used and thus affect cleaning methods.

Considerations for Cleaning Biopharmaceutical Process Equipment

AkesoBio’s expanded manufacturing capacity, enabled by the addition of another Cytiva FlexFactory platform, will be used to meet current and future market needs in China as well as worldwide.

Cytiva Provides Another FlexFactory Single-Use Platform for AkesoBio’s Manufacturing Expansion

The new facility, which will be Evotec’s first in Europe, will aim to offer capacity, flexibility, and quality for biotherapeutic development and manufacturing while utilizing technology that employs small, automated, highly intensified, and continuous bioprocessing operations inside autonomous cleanrooms.

Evotec Launches Biomanufacturing Facility in France

The transaction is set to close during the first half of 2021 and is expected to enhance drug substance and drug product capabilities for WuXi. 

WuXi Biologics to Acquire Pfizer China’s Biologics Manufacturing Facilities 

The CGMP manufacturing agreement will expand production of lenzilumab, a candidate for COVID-19 therapy, to support a potential emergency use authorization filing.

Avid Bioservices Enters Manufacturing Agreement with Humanigen for Lenzilumab

Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%. 

rBIO Hits Key Lab Milestone with Synthetic Production of Insulin

The grant will support the advancement of glycoengineering technology for plant-derived proteins developed by a University of Alberta scientist partnered with PlantForm.

NSERC Awards Alliance Grant to PlantForm to Enable Commercial-Scale Production of Protein Therapeutics

Pharmaceutical Technology spoke with Tania Pereira Chilima, Deputy CTO at Univercells Technologies about their technology and how it can be used in viral vector manufacturing, which is needed for production of some of the COVID-19 vaccine candidates. 

Intensifed Process Offers Cost-Effective Viral Vector Manufacturing

The new super plant, being built in Incheon, South Korea, will have a total biopharmaceutical manufacturing capacity of 256,000 L.

Manufacturing, Biologic Drugs